Diethylpropion Hydrochloride ER (DIETHYLPROPION HYDROCHLORIDE)
Diethylpropion Hydrochloride ER (DIETHYLPROPION HYDROCHLORIDE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Diethylpropion Hydrochloride ER; Generic name: DIETHYLPROPION HYDROCHLORIDE; Manufacturer: PD-Rx Pharmaceuticals, Inc..
| Brand name | Diethylpropion Hydrochloride ER |
|---|---|
| Generic name | DIETHYLPROPION HYDROCHLORIDE |
| Manufacturer | PD-Rx Pharmaceuticals, Inc. |
| Used for | INDICATIONS AND USAGE Diethylpropion hydrochloride extended release tablets, 75 mg are indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of BMI based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. Body Mass Index (B |
| Dosage | DOSAGE AND ADMINISTRATION Diethylpropion Hydrochloride Extended Release Tablets, 75 mg: One extended-release 75 mg tablet daily, swallowed whole, in midmorning. Geriatric use: This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal functi |
| Warnings | WARNINGS Diethylpropion hydrochloride extended release tablets, 75 mg should not be used in combination with other anorectic agents, including prescribed drugs, over-the-counter preparations, and herbal products. In a case-control epidemiological study, the use of anorectic agents, including diethylpropion, was associated with an increased risk of developing pulmonary hypertension, a rare, but often fatal disorder. The use of anorectic agents for longer than 3 months was associated with a 23-fol |
| Active ingredient(s) | DIETHYLPROPION HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0d213a24-ebbf-41df-8f32-de44a572829e |